{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T00:03:56Z","timestamp":1758672236022,"version":"3.44.0"},"reference-count":62,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2012,10,1]],"date-time":"2012-10-01T00:00:00Z","timestamp":1349049600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,10,1]],"date-time":"2012-10-01T00:00:00Z","timestamp":1349049600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2013,10,10]],"date-time":"2013-10-10T00:00:00Z","timestamp":1381363200000},"content-version":"vor","delay-in-days":374,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"name":"National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services","award":["Y1-AI-0681-01"],"award-info":[{"award-number":["Y1-AI-0681-01"]}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Virology"],"published-print":{"date-parts":[[2012,10]]},"DOI":"10.1016\/j.virol.2012.05.034","type":"journal-article","created":{"date-parts":[[2012,7,5]],"date-time":"2012-07-05T09:50:32Z","timestamp":1341481832000},"page":"173-183","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Virological and molecular characterization of a simian human immunodeficiency virus (SHIV) encoding the envelope and reverse transcriptase genes from HIV-1"],"prefix":"10.1016","volume":"432","author":[{"given":"Ranajit","family":"Pal","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lindsey","family":"Galmin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lara E.","family":"Pereira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bin","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jining","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jesse","family":"Francis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janet M.","family":"McNicholl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deborah E.","family":"Weiss","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James M.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.virol.2012.05.034_bib1","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1126\/science.1193748","article-title":"Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women","volume":"329","author":"Abdool Karim","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.virol.2012.05.034_bib2","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1099\/vir.0.18843-0","article-title":"Construction and in vivo infection of a new simian\/human immunodeficiency virus chimera containing the reverse transcriptase gene and the 3\u2032 half of the genomic region of human immunodeficiency virus type 1","volume":"84","author":"Akiyama","year":"2003","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.virol.2012.05.034_bib3","doi-asserted-by":"crossref","first-page":"13553","DOI":"10.1128\/JVI.78.24.13553-13561.2004","article-title":"In vitro characterization of a simian immunodeficiency virus-human immunodeficiency virus (HIV) chimera expressing HIV type 1 reverse transcriptase to study antiviral resistance in pigtail macaques","volume":"78","author":"Ambrose","year":"2004","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2012.05.034_bib4","doi-asserted-by":"crossref","first-page":"12145","DOI":"10.1128\/JVI.01301-07","article-title":"Suppression of viremia and evolution of human immunodeficiency virus type 1 drug resistance in a macaque model for antiretroviral therapy","volume":"81","author":"Ambrose","year":"2007","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2012.05.034_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00042560-199705010-00001","article-title":"SIV\/HIV-1 hybrid virus expressing the reverse transcriptase gene of HIV-1 remains sensitive to HIV-1-specific reverse transcriptase inhibitors after passage in rhesus macaques","volume":"15","author":"Balzarini","year":"1997","journal-title":"J. Acquir. Immune Defic. Syndr. Hum. Retrovirol."},{"key":"10.1016\/j.virol.2012.05.034_bib6","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/S0026-895X(25)09254-5","article-title":"Highly favorable antiviral activity and resistance profile of the novel thiocarboxanilide pentenyloxy ether derivatives UC-781 and UC-82 as inhibitors of human immunodeficiency virus type 1 replication","volume":"50","author":"Balzarini","year":"1996","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.virol.2012.05.034_bib7","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1097\/QAD.0b013e3282f3ca57","article-title":"Protection of macaques against vaginal SHIV challenge by systemic or mucosal and systemic vaccinations with HIV-envelope","volume":"22","author":"Barnett","year":"2008","journal-title":"Aids"},{"key":"10.1016\/j.virol.2012.05.034_bib8","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1128\/AAC.00972-07","article-title":"Comparative evaluation of the inhibitory activities of a series of pyrimidinedione congeners that inhibit human immunodeficiency virus types 1 and 2","volume":"52","author":"Buckheit","year":"2008","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.virol.2012.05.034_bib9","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1177\/095632020701800502","article-title":"The structure-activity relationships of 2,4(1H,3H)-pyrimidinedione derivatives as potent HIV type 1 and type 2 inhibitors","volume":"18","author":"Buckheit","year":"2007","journal-title":"Antivir. Chem. Chemother."},{"key":"10.1016\/j.virol.2012.05.034_bib10","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1128\/AAC.45.2.393-400.2001","article-title":"SJ-3366, a unique and highly potent nonnucleoside reverse transcriptase inhibitor of human immunodeficiency virus type 1 (HIV-1) that also inhibits HIV-2","volume":"45","author":"Buckheit","year":"2001","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.virol.2012.05.034_bib11","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/0065-2571(84)90007-4","article-title":"Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors","volume":"22","author":"Chou","year":"1984","journal-title":"Adv. Enzyme Regul."},{"key":"10.1016\/j.virol.2012.05.034_bib12","doi-asserted-by":"crossref","first-page":"7933","DOI":"10.1128\/JVI.00843-11","article-title":"Protection against rectal transmission of an emtricitabine-resistant simian\/human immunodeficiency virus SHIV162p3M184V mutant by intermittent prophylaxis with Truvada","volume":"85","author":"Cong","year":"2011","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2012.05.034_bib13","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.virol.2007.04.012","article-title":"HIV-1 prophylactic vaccine comprised of topical DermaVir prime and protein boost elicits cellular immune responses and controls pathogenic R5 SHIV162P3","volume":"366","author":"Cristillo","year":"2007","journal-title":"Virology"},{"key":"10.1016\/j.virol.2012.05.034_bib14","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.bbrc.2007.11.052","article-title":"Persistent antibody and T cell responses induced by HIV-1 DNA vaccine delivered by electroporation","volume":"366","author":"Cristillo","year":"2008","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.virol.2012.05.034_bib15","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1097\/QAI.0b013e3182234a51","article-title":"Delayed maturation of antibody avidity but not seroconversion in rhesus macaques infected with simian HIV during oral pre-exposure prophylaxis","volume":"57","author":"Curtis","year":"2011","journal-title":"J. Acquir. Immune Defic. Syndr."},{"key":"10.1016\/j.virol.2012.05.034_bib16","doi-asserted-by":"crossref","first-page":"315","DOI":"10.2174\/1381612043386374","article-title":"Clinical development of microbicides for the prevention of HIV infection","volume":"10","author":"D'Cruz","year":"2004","journal-title":"Curr. Pharm. Des."},{"issue":"Suppl 3","key":"10.1016\/j.virol.2012.05.034_bib17","first-page":"S43","article-title":"Female-controlled methods to prevent sexual transmission of HIV","volume":"10","author":"Elias","year":"1996","journal-title":"Aids"},{"key":"10.1016\/j.virol.2012.05.034_bib18","doi-asserted-by":"crossref","first-page":"11179","DOI":"10.1128\/JVI.79.17.11179-11186.2005","article-title":"The nonnucleoside reverse transcriptase inhibitor UC-781 inhibits human immunodeficiency virus type 1 infection of human cervical tissue and dissemination by migratory cells","volume":"79","author":"Fletcher","year":"2005","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2012.05.034_bib19","doi-asserted-by":"crossref","first-page":"6610","DOI":"10.1128\/JVI.00311-11","article-title":"Natural substrate concentrations can modulate the prophylactic efficacy of nucleotide HIV reverse transcriptase inhibitors","volume":"85","author":"Garcia-Lerma","year":"2011","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2012.05.034_bib20","doi-asserted-by":"crossref","first-page":"e28","DOI":"10.1371\/journal.pmed.0050028","article-title":"Prevention of rectal SHIV transmission in macaques by daily or intermittent prophylaxis with emtricitabine and tenofovir","volume":"5","author":"Garcia-Lerma","year":"2008","journal-title":"PLoS Med."},{"key":"10.1016\/j.virol.2012.05.034_bib21","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1177\/095632020901900401","article-title":"The future of HIV microbicides: challenges and opportunities","volume":"19","author":"Garg","year":"2009","journal-title":"Antivir. Chem. Chemother."},{"key":"10.1016\/j.virol.2012.05.034_bib22","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1126\/science.1160355","article-title":"Whither or wither microbicides?","volume":"321","author":"Grant","year":"2008","journal-title":"Science"},{"key":"10.1016\/j.virol.2012.05.034_bib23","doi-asserted-by":"crossref","first-page":"2587","DOI":"10.1056\/NEJMoa1011205","article-title":"Preexposure chemoprophylaxis for HIV prevention in men who have sex with men","volume":"363","author":"Grant","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.virol.2012.05.034_bib24","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1128\/JVI.75.4.1990-1995.2001","article-title":"Mucosal transmission and induction of simian AIDS by CCR5-specific simian\/human immunodeficiency virus SHIV(SF162P3)","volume":"75","author":"Harouse","year":"2001","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2012.05.034_bib25","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1186\/1742-4690-5-94","article-title":"SHIV-1157i and passaged progeny viruses encoding R5 HIV-1 clade C env cause AIDS in rhesus monkeys","volume":"5","author":"Humbert","year":"2008","journal-title":"Retrovirology"},{"issue":"Suppl 1","key":"10.1016\/j.virol.2012.05.034_bib26","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/j.1600-0684.2009.00374.x","article-title":"Macaca fascicularis are highly susceptible to an RT-SHIV following intravaginal inoculation: a new model for microbicide evaluation","volume":"38","author":"Jiang","year":"2009","journal-title":"J. Med. Primatol."},{"key":"10.1016\/j.virol.2012.05.034_bib27","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.virusres.2008.01.003","article-title":"Novel HIV-1 reverse transcriptase inhibitors","volume":"134","author":"Jochmans","year":"2008","journal-title":"Virus Res."},{"key":"10.1016\/j.virol.2012.05.034_bib28","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1111\/j.1600-0684.2006.00169.x","article-title":"Repetitive exposures with simian\/human immunodeficiency viruses: strategy to study HIV pre-clinical interventions in non-human primates","volume":"35","author":"Kim","year":"2006","journal-title":"J. Med. Primatol."},{"key":"10.1016\/j.virol.2012.05.034_bib29","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1089\/aid.2006.0076","article-title":"Evaluation of -2 RANTES vaginal microbicide formulations in a nonhuman primate simian\/human immunodeficiency virus (SHIV) challenge model","volume":"23","author":"Kish-Catalone","year":"2007","journal-title":"AIDS Res. Hum. Retroviruses"},{"key":"10.1016\/j.virol.2012.05.034_bib30","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1146\/annurev.med.59.061206.112737","article-title":"Antiretroviral drug-based microbicides to prevent HIV-1 sexual transmission","volume":"59","author":"Klasse","year":"2008","journal-title":"Annu. Rev. Med."},{"key":"10.1016\/j.virol.2012.05.034_bib31","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.0030351","article-title":"Which topical microbicides for blocking HIV-1 transmission will work in the real world?","volume":"3","author":"Klasse","year":"2006","journal-title":"PLoS Med."},{"key":"10.1016\/j.virol.2012.05.034_bib32","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1097\/COH.0b013e328322402e","article-title":"HIV-1 entry inhibitors: an overview","volume":"4","author":"Kuritzkes","year":"2009","journal-title":"Curr. Opin. HIV AIDS"},{"key":"10.1016\/j.virol.2012.05.034_bib33","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1038\/nri1848","article-title":"Microbicides and other topical strategies to prevent vaginal transmission of HIV","volume":"6","author":"Lederman","year":"2006","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.virol.2012.05.034_bib34","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1126\/science.1099288","article-title":"Prevention of vaginal SHIV transmission in rhesus macaques through inhibition of CCR5","volume":"306","author":"Lederman","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.virol.2012.05.034_bib35","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.jviromet.2009.10.012","article-title":"Molecular methods for evaluation of virological status of nonhuman primates challenged with simian immunodeficiency or simian\u2013human immunodeficiency viruses","volume":"163","author":"Lee","year":"2010","journal-title":"J. Virol. Methods"},{"key":"10.1016\/j.virol.2012.05.034_bib36","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1097\/00002030-200207260-00005","article-title":"SIV(mac) pathogenesis in rhesus macaques of Chinese and Indian origin compared with primary HIV infections in humans","volume":"16","author":"Ling","year":"2002","journal-title":"Aids"},{"key":"10.1016\/j.virol.2012.05.034_bib37","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1111\/j.1600-0684.2010.00465.x","article-title":"Hormonal synchronization of the menstrual cycles of pigtail macaques to facilitate biomedical research including modeling HIV susceptibility","volume":"40","author":"Livingston","year":"2011","journal-title":"J. Med. Primatol."},{"key":"10.1016\/j.virol.2012.05.034_bib38","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1038\/nm1096-1084","article-title":"Progesterone implants enhance SIV vaginal transmission and early virus load","volume":"2","author":"Marx","year":"1996","journal-title":"Nat. Med."},{"key":"10.1016\/j.virol.2012.05.034_bib39","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1097\/QCO.0b013e328334fe70","article-title":"Microbicides for HIV prevention: reality or hope?","volume":"23","author":"McGowan","year":"2010","journal-title":"Curr. Opin. Infect. Dis."},{"key":"10.1016\/j.virol.2012.05.034_bib40","unstructured":"Network, M.T., 2011. Microbicide trials network statement on decision to discontinue use of Tenofovir gel in VOICE, a major HIV prevention study in women. In: Microbicide Trials Network; 2011."},{"key":"10.1016\/j.virol.2012.05.034_bib41","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1086\/426452","article-title":"Multiple vaginal exposures to low doses of R5 simian\u2013human immunodeficiency virus: strategy to study HIV preclinical interventions in nonhuman primates","volume":"191","author":"Otten","year":"2005","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.virol.2012.05.034_bib42","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1089\/aid.2004.20.1157","article-title":"RC-101, a retrocyclin-1 analogue with enhanced activity against primary HIV type 1 isolates","volume":"20","author":"Owen","year":"2004","journal-title":"AIDS Res. Hum. Retroviruses"},{"key":"10.1016\/j.virol.2012.05.034_bib43","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.virol.2009.01.002","article-title":"Characterization of vaginal transmission of a simian human immunodeficiency virus (SHIV) encoding the reverse transcriptase gene from HIV-1 in Chinese rhesus macaques","volume":"386","author":"Pal","year":"2009","journal-title":"Virology"},{"key":"10.1016\/j.virol.2012.05.034_bib44","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1097\/00126334-200307010-00003","article-title":"Characterization of a simian human immunodeficiency virus encoding the envelope gene from the CCR5-tropic HIV-1 Ba-L","volume":"33","author":"Pal","year":"2003","journal-title":"J. Acquir. Immune Defic. Syndr."},{"key":"10.1016\/j.virol.2012.05.034_bib45","doi-asserted-by":"crossref","first-page":"10358","DOI":"10.1128\/JVI.01073-09","article-title":"Complete protection from repeated vaginal simian\u2013human immunodeficiency virus exposures in macaques by a topical gel containing tenofovir alone or with emtricitabine","volume":"83","author":"Parikh","year":"2009","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2012.05.034_bib46","doi-asserted-by":"crossref","first-page":"5744","DOI":"10.1016\/j.bmc.2009.06.060","article-title":"The search for potent, small molecule NNRTIs: a review","volume":"17","author":"Prajapati","year":"2009","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.virol.2012.05.034_bib47","unstructured":"Prevention, C.f.D.C.a., 2011. CDC trial and another major study find PrEP can reduce risk of HIV infection among heterosexuals. In: Centers for Disease Control and Prevention; 2011."},{"issue":"Suppl 4","key":"10.1016\/j.virol.2012.05.034_bib48","doi-asserted-by":"crossref","first-page":"S40","DOI":"10.1097\/01.aids.0000390706.81383.f3","article-title":"The last decade of microbicide clinical trials in Africa: from hypothesis to facts","volume":"24","author":"Ramjee","year":"2010","journal-title":"Aids"},{"key":"10.1016\/j.virol.2012.05.034_bib49","doi-asserted-by":"crossref","first-page":"8878","DOI":"10.1128\/JVI.79.14.8878-8885.2005","article-title":"Pathogenicity of simian\u2013human immunodeficiency virus SHIV-89.6P and SIVmac is attenuated in cynomolgus macaques and associated with early T-lymphocyte responses","volume":"79","author":"Reimann","year":"2005","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2012.05.034_bib50","doi-asserted-by":"crossref","first-page":"3952","DOI":"10.1128\/JVI.02660-07","article-title":"Deciphering human immunodeficiency virus type 1 transmission and early envelope diversification by single-genome amplification and sequencing","volume":"82","author":"Salazar-Gonzalez","year":"2008","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2012.05.034_bib51","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1128\/JVI.02066-08","article-title":"Neutralization-sensitive R5-tropic simian\u2013human immunodeficiency virus SHIV-2873Nip, which carries env isolated from an infant with a recent HIV clade C infection","volume":"83","author":"Siddappa","year":"2009","journal-title":"J. Virol."},{"issue":"Suppl 1","key":"10.1016\/j.virol.2012.05.034_bib52","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1186\/1479-5876-9-S1-S7","article-title":"Coreceptor use in nonhuman primate models of HIV infection","volume":"9","author":"Sina","year":"2011","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.virol.2012.05.034_bib53","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/j.1600-0684.2010.00434.x","article-title":"Generation of a dual RT Env SHIV that is infectious in rhesus macaques","volume":"39","author":"Smith","year":"2010","journal-title":"J. Med. Primatol."},{"key":"10.1016\/j.virol.2012.05.034_bib54","doi-asserted-by":"crossref","first-page":"5803","DOI":"10.1128\/JVI.76.11.5803-5806.2002","article-title":"A nucleotide substitution in the tRNA(Lys) primer binding site dramatically increases replication of recombinant simian immunodeficiency virus containing a human immunodeficiency virus type 1 reverse transcriptase","volume":"76","author":"Soderberg","year":"2002","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2012.05.034_bib56","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1034\/j.1600-0684.2002.02003.x","article-title":"Species-specific variation in SIV disease progression between Chinese and Indian subspecies of rhesus macaque","volume":"31","author":"Trichel","year":"2002","journal-title":"J. Med. Primatol."},{"key":"10.1016\/j.virol.2012.05.034_bib57","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1089\/088922204322749459","article-title":"Cyanovirin-N inhibits AIDS virus infections in vaginal transmission models","volume":"20","author":"Tsai","year":"2004","journal-title":"AIDS Res. Hum. Retroviruses"},{"key":"10.1016\/j.virol.2012.05.034_bib58","unstructured":"UNAIDS, 2010. UNAIDS Report on the Global AIDS Epidemic. In: UNAIDS Global Report; 2010."},{"key":"10.1016\/j.virol.2012.05.034_bib59","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.1097\/QAD.0b013e3282ef83fd","article-title":"Vaginal microbicides: moving ahead after an unexpected setback","volume":"21","author":"van de Wijgert","year":"2007","journal-title":"Aids"},{"key":"10.1016\/j.virol.2012.05.034_bib60","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1097\/COH.0b013e32830891bb","article-title":"Microbicide safety\/efficacy studies in animals: macaques and small animal models","volume":"3","author":"Veazey","year":"2008","journal-title":"Curr. Opin. HIV AIDS"},{"key":"10.1016\/j.virol.2012.05.034_bib61","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1086\/655661","article-title":"Protection of rhesus macaques from vaginal infection by vaginally delivered maraviroc, an inhibitor of HIV-1 entry via the CCR5 co-receptor","volume":"202","author":"Veazey","year":"2010","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.virol.2012.05.034_bib62","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/nature04055","article-title":"Protection of macaques from vaginal SHIV challenge by vaginally delivered inhibitors of virus-cell fusion","volume":"438","author":"Veazey","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.virol.2012.05.034_bib63","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1086\/598685","article-title":"Topically applied recombinant chemokine analogues fully protect macaques from vaginal simian\u2013human immunodeficiency virus challenge","volume":"199","author":"Veazey","year":"2009","journal-title":"J. Infect. Dis."}],"container-title":["Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0042682212002851?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0042682212002851?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T00:16:25Z","timestamp":1758586585000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0042682212002851"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,10]]},"references-count":62,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,10]]}},"alternative-id":["S0042682212002851"],"URL":"https:\/\/doi.org\/10.1016\/j.virol.2012.05.034","relation":{},"ISSN":["0042-6822"],"issn-type":[{"type":"print","value":"0042-6822"}],"subject":[],"published":{"date-parts":[[2012,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Virological and molecular characterization of a simian human immunodeficiency virus (SHIV) encoding the envelope and reverse transcriptase genes from HIV-1","name":"articletitle","label":"Article Title"},{"value":"Virology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.virol.2012.05.034","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Elsevier Inc. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}